FDA: Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation

https://www.fda.gov/media/143557/download

slide 16 or 17



FDA Safety Surveillance of COVID-19 Vaccines
DRAFT Working list of possible adverse event outcomes==
--Subject to change--

- Guillain-Barré syndrome
- Acute disseminated encephalomyelitis
- Transverse myelitis
- Encephalitis/myelitis/encephalomyelitis/ meningoencephalitis/meningitis/ encepholapathy
- Convulsions/seizures